Impact of a PMMA tube on performances of a Vereos PET/CT system adapted for BSL-3 environment according to the NEMA NU2-2012 standard.
Nidhal KahlaouiThibaut NaninckRoger Le GrandCatherine ChaponPublished in: EJNMMI physics (2022)
Question. Does a BSL-3 compatible modification alter Philips Vereos PET/CT performances according to NEMA NU2-2012 standards? Pertinent findings. Our Vereos PET/CT system was modified by a wall separating BSL-1 and BSL-3 sides and an 8 mm thickness PMMA tube inserted into the bore of the camera in order to extend the BSL-3 containment along the bed movement. The performances of our modified system according to NEMA NU2-2012 standards were not significantly impacted by the modifications and were in accordance with the values prescribed by the manufacturer. Implications for patients care. Our clinical PET/CT device was modified for human infectious diseases studies in Non-Human Primates. This unusual set up may then provide truly transposable data from preclinical studies into clinical application in infected patients.
Keyphrases
- pet ct
- endothelial cells
- infectious diseases
- positron emission tomography
- end stage renal disease
- induced pluripotent stem cells
- healthcare
- ejection fraction
- newly diagnosed
- chronic kidney disease
- pluripotent stem cells
- case control
- prognostic factors
- stem cells
- electronic health record
- big data
- optical coherence tomography
- cell therapy
- high resolution
- bone marrow
- patient reported
- deep learning
- data analysis